Ding, Q., Tian, X., Li, Y., Wang, Q., & Zhang, C. (2015). Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World J Gastroenterol.
Chicago-tyylinen lähdeviittausDing, Qian, Xiang-Guo Tian, Yan Li, Qi-Zhi Wang, ja Chun-Qing Zhang. "Carvedilol May Attenuate Liver Cirrhosis By Inhibiting Angiogenesis Through the VEGF-Src-ERK Signaling Pathway." World J Gastroenterol 2015.
MLA-viiteDing, Qian, et al. "Carvedilol May Attenuate Liver Cirrhosis By Inhibiting Angiogenesis Through the VEGF-Src-ERK Signaling Pathway." World J Gastroenterol 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.